Xiamen Amoytop Biotech Co., Ltd.

Xiamen Amoytop Biotech provides research, development, production, and sale of recombinant protein drugs in China and globally. It offers various drug products, including pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin.

Its portfolio also includes active pharmaceutical ingredients (APIs), and reagents to treat viral hepatitis, malignant tumors, and immunotherapy. Founded in 1996, Xiamen Amoytop Biotech is headquartered in Xiamen, China.